Drug for inhibiting vascular intimal hyperplasia

Details for Australian Patent Application No. 2005210326 (hide)

Owner Taisho Pharmaceutical Co., Ltd. Nissan Chemical Industries, Ltd.

Inventors Tsuruzoe, Nobutomo; Nishiyama, Hiroshi; Shudo, Norimasa

Agent Davies Collison Cave

Pub. Number AU-B-2005210326

PCT Pub. Number WO2005/074938

Priority 2004-032551 09.02.04 JP

Filing date 2 February 2005

Wipo publication date 18 August 2005

Acceptance publication date 22 October 2009

International Classifications

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

C07D 237/14 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/074938 Priority application(s): WO2005/074938

22 October 2009 Application Accepted

  Published as AU-B-2005210326

18 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210349-Method for separating/refining cationic protein

2005210321-Coating method and production method for dimming lens